What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the optimal selection of anti-arrhythmic drugs. The virtual cohort considered variability in electrophysio...
Main Authors: | Dasí, A, Pope, MTB, Wijesurendra, RS, Betts, TR, Sachetto, R, Bueno Orovio, A, Rodriguez, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2023
|
Similar Items
-
In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study
by: Dasí, A, et al.
Published: (2024) -
In-silico drug trials for precision medicine in atrial fibrillation: from ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
by: Dasí, A, et al.
Published: (2022) -
Atrial fibrillation dynamics and ionic block effects in six heterogeneous human 3D virtual atria with distinct repolarization dynamics
by: Sánchez, C, et al.
Published: (2017) -
Mechanisms of atrial fibrillation
by: Wijesurendra, RS, et al.
Published: (2019) -
Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
by: Farzad Rahbar Kouibaran, et al.
Published: (2023-03-01)